Literature DB >> 25042667

Unusual presentation of hypothalamic hamartoma with hypersomnia in an adult patient.

F Irsel Tezer1, Mehmet Yasir Pektezel1, Rahsan Gocmen2, Serap Saygi1.   

Abstract

We report a patient with polysomnography findings related to hypersomnia, as a primary presenting symptom, who was shown to have stereotypical gelastic seizures. Her cranial magnetic resonance imaging revealed a hypothalamic hamartoma in the posterior region of the hypothalamus. The patient had no previous history of gelastic seizures. We suggest that patients who present with hypersomnia should be investigated for gelastic seizures in order to avoid misdiagnosis and receive appropriate treatment.

Entities:  

Keywords:  gelastic seizure; hypersomnia; hypothalamic hamartoma; polysomnography (PSG); seizure; sleep

Mesh:

Year:  2014        PMID: 25042667     DOI: 10.1684/epd.2014.0669

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  4 in total

1.  Hypersomnia due to injury of the ventral ascending reticular activating system following cerebellar herniation: A case report.

Authors:  Sung Ho Jang; Chul Hoon Chang; Young Jin Jung; Hyeok Gyu Kwon
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

2.  Hypothalamic hamartomas in adulthood: Clinical spectrum and treatment outcome-A unicenter experience.

Authors:  Estefanía Conde Blanco; Carla Anciones Martín; Isabel Manzanares; Francisco Gil López; Pedro Roldán; Antonio Donaire; Jordi Rumiá; Mar Carreño
Journal:  Brain Behav       Date:  2019-10-02       Impact factor: 2.708

3.  Ischemic Stroke of Midbrain and Cerebellum Involving Reticular Activating System.

Authors:  Waleed Sadiq; Madeeha Subhan
Journal:  Cureus       Date:  2017-09-01

4.  Recovery of Hypersomnia Concurrent With Recovery of an Injured Ascending Reticular Activating System in a Stroke Patient: A Case Report.

Authors:  Sung Ho Jang; Han Do Lee; Chul Hoon Chang; Young Jin Jung
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.